Lucie Rigolot

7PUBLICATIONS
62CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Haematological tumoursBiomedical engineering not elsewhere classifiedMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 10, 2026
Targeted Next-Generation Sequencing of JAK2, CALR, and MPL in 10 326 Patients With Suspected Myeloproliferative Neoplasm.

|May 21, 2026
Prognostic impact of FLT3-ITD microclones in young adults with acute myeloid leukemia treated with intensive chemotherapy.

|May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX.

Vincent Jachiet, Olivier Kosmider, Maxime Beydon

|Dec 12, 2024
S56F UBA1 variant: a VEXAS syndrome subtype that follows its own path.

Jean-Baptiste Rieu, Lucie Rigolot

|Apr 18, 2024
A case of acute megakaryoblastic leukaemia following a mediastinal germ cell tumour.

PierreLuc Mairiniac, Lucie Rigolot, Sarah Bertoli

|Feb 24, 2024
Minimal Residual Disease in Acute Myeloid Leukemia: Old and New Concepts.

Mathias Chea, Lucie Rigolot, Alban Canali

Pageof 2

Frequent Collaborators

3 joint publications

Eric Delabesse

3 joint publications

Jean-Baptiste Rieu

2 joint publications

Mael Heiblig

2 joint publications

Nicolas Duployez